Immunity targeting common core antigens of gram-negative bacteria.

Antibodies against common gram-negative core antigens can provide protection against environmental, commensual, and contagious bacteria that cause life-threatening gram-negative sepsis/endotoxemia. Cross-protective immunity may be effective against many common livestock diseases, including neonatal coliform septicemia, coliform mastitis, septic metritis, and severe enteritis. The greatest potential benefit of cross-protective immunity may be realized in the reduction of ill-thrift and mortality of neonates. The use of active and passive immunization against core antigens common to gram-negative bacteria has been successful in human beings, laboratory animals, and livestock. Protection has been observed following challenge with either heterologous endotoxin or unrelated, live, virulent gram-negative bacteria.

[1]  M. Thurmond,et al.  Rapid decay of serum IgG recognizing gram-negative cell wall core antigens in neonatal calves. , 1989, American journal of veterinary research.

[2]  J. Snyder,et al.  Protection against clinical endotoxemia in horses by using plasma containing antibody to an Rc mutant E. coli (J5). , 1989, Circulatory shock.

[3]  K. Parker,et al.  Preferential decay of passively acquired immunoglobulins recognizing shared gram-negative core antigens in neonatal swine. , 1989, American journal of veterinary research.

[4]  M. Thurmond,et al.  Humoral recognition of lipopolysaccharide core antigens of gram-negative bacteria in neonatal swine. , 1989, American journal of veterinary research.

[5]  J. Cullor,et al.  Relationship between serologic recognition of Escherichia coli 0111:B4 (J5) and clinical coliform mastitis in cattle. , 1988, American journal of veterinary research.

[6]  K. Parker,et al.  Age-related variations in serum concentrations of the third component of complement in swine. , 1988, American journal of veterinary research.

[7]  Banks Kl,et al.  Contribution of various host factors to resistance to experimentally induced bacterial endotoxemia in calves. , 1988 .

[8]  S. E. Greisman,et al.  Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality. , 1988, The Journal of infectious diseases.

[9]  G. Barclay,et al.  Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies , 1987, Infection and immunity.

[10]  D. D. Morris,et al.  Therapy of suspected septicemia in neonatal foals using plasma-containing antibodies to core lipopolysaccharide (LPS). , 1987, Journal of veterinary internal medicine.

[11]  L. Corbeil,et al.  Cross-reactive antibody in immunity to colisepticemia in calves. , 1987, Veterinary microbiology.

[12]  D. D. Morris,et al.  Endotoxin-induced changes in the hemostatic system in neonatal calves: the effect of antiserum to a mutant Escherichia coli (J-5). , 1986, American journal of veterinary research.

[13]  D. D. Morris,et al.  Endotoxemia in neonatal calves given antiserum to a mutant Escherichia coli (J-5). , 1986, American journal of veterinary research.

[14]  S. Gaffin,et al.  Hypoxia-induced endotoxemia in primates: role of reticuloendothelial system function and anti-lipopolysaccharide plasma. , 1986, Aviation, space, and environmental medicine.

[15]  J. Cullor,et al.  Mortality in swine herds endemically infected with Haemophilus pleuropneumoniae: effect of immunization with cross-reacting lipopolysaccharide core antigens of Escherichia coli. , 1986, American journal of veterinary research.

[16]  B. Osburn,et al.  Resistance of C3H/HeJ mice to the effects of Haemophilus pleuropneumoniae , 1986, Infection and immunity.

[17]  J. Cullor,et al.  Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine , 1986, Infection and immunity.

[18]  D. D. Morris,et al.  Endotoxemia in horses: protection provided by antiserum to core lipopolysaccharide. , 1986, American journal of veterinary research.

[19]  J. Cullor,et al.  Active Immunization with E. Coli J5 and its Protective Effects from Endotoxic Shock in Calves , 1986 .

[20]  G. Hardee,et al.  Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor. , 1986, American journal of veterinary research.

[21]  F. Cerra,et al.  Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection. , 1986, Archives of surgery.

[22]  J. McCutchan,et al.  PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID , 1985, The Lancet.

[23]  J. Shenep,et al.  Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli. , 1985, The Journal of infectious diseases.

[24]  J. Woolcock.  Pathogenesis of bacterial infections: some determinants of virulence in Gram negative bacteria. , 1985, Australian veterinary journal.

[25]  G. Domingue,et al.  Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5. , 1985, The Journal of infectious diseases.

[26]  J. Shenep,et al.  Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. , 1985, The Journal of infectious diseases.

[27]  M. Marks,et al.  Age-related prevalence of human serum IgG and IgM antibody to the core glycolipid of Escherichia coli strain J5, as measured by ELISA. , 1985, The Journal of infectious diseases.

[28]  H. Kaplan,et al.  Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Cohen,et al.  Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. , 1984, The Journal of infectious diseases.

[30]  M. Nelles,et al.  Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria , 1984, Infection and immunity.

[31]  J. Shenep,et al.  Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis. , 1984, The Journal of infectious diseases.

[32]  R. Hancock,et al.  Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species , 1984, Infection and immunity.

[33]  B. Brewer,et al.  Clinical and clinicopathological characteristics of the septicaemic neonatal foal: review of 38 cases. , 1984, Equine veterinary journal.

[34]  M. Reina-Guerra,et al.  Relationship of cutaneous delayed hypersensitivity to protection from challenge exposure with Salmonella typhimurium in calves. , 1984, American journal of veterinary research.

[35]  S. Gaffin,et al.  ANTI-LIPOPOLYSACCHARIDE IMMUNOTHERAPY IN MANAGEMENT OF SEPTIC SHOCK OF OBSTETRIC AND GYNAECOLOGICAL ORIGIN , 1984, The Lancet.

[36]  T. Kirkland,et al.  An immunoprotective monoclonal antibody to lipopolysaccharide. , 1984, Journal of immunology.

[37]  E. J. Carroll,et al.  Role of prostaglandins in pathogenesis of bovine mastitis induced by Escherichia coli endotoxin. , 1984, American journal of veterinary research.

[38]  E. J. Carroll,et al.  Changes of complement values in calves during the first month of life. , 1983, American journal of veterinary research.

[39]  E. Ziegler,et al.  Protection against Gram-Negative Bacteremia with Antiserum to Endotoxins , 1983 .

[40]  W. R. Mccabe,et al.  Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. , 1983, The Journal of infectious diseases.

[41]  B. Osburn,et al.  Ontogeny of the immune system. , 1982, Journal of the American Veterinary Medical Association.

[42]  J. Fierer,et al.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. , 1982, The New England journal of medicine.

[43]  D. Dunn,et al.  Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5. , 1982, Surgery.

[44]  E. Ziegler,et al.  Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. , 1982, The Journal of clinical investigation.

[45]  J. Katzwinkel,et al.  Prophylaxis and therapy with anti-endotoxin hyperimmune serum against gastroenteritis and endotoxemia in horses. , 1982 .

[46]  G. Bottoms,et al.  Endotoxin-induced change in hemograms, plasma enzymes, and blood chemical values in anesthetized ponies: effects of flunixin meglumine. , 1982, American journal of veterinary research.

[47]  J. Pennington,et al.  Type-specific vs. cross-protective vaccination for gram-negative bacterial pneumonia. , 1981, The Journal of infectious diseases.

[48]  B. P. Smith,et al.  Immunization of calves against salmonellosis. , 1980, American journal of veterinary research.

[49]  W. R. Mccabe,et al.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. , 1980, The American journal of medicine.

[50]  R. Macdermott,et al.  Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. , 1980, Journal of immunology.

[51]  B. Hartley‐åsp.  MUTAGENICITY OF METRONIDAZOLE , 1979, The Lancet.

[52]  S. Bradley.  Cellular and molecular mechanisms of action of bacterial endotoxins. , 1979, Annual review of microbiology.

[53]  A. Winter.  Mechanisms of immunity in bacterial infections. , 1979, Advances in veterinary science and comparative medicine.

[54]  R. Ulevitch,et al.  The effects of bacterial endotoxins on host mediation systems. A review. , 1978, The American journal of pathology.

[55]  J. McCutchan,et al.  Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. , 1977, Journal of Infectious Diseases.

[56]  D. Morrison,et al.  Lipid A as the biologically active moiety in bacterial endotoxin (LPS)-initiated generation of procoagulant activity by peripheral blood leukocytes. , 1977, Blood.

[57]  D. Morrison,et al.  Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. , 1977, Journal of immunology.

[58]  L. Kline,et al.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). , 1977, Journal of immunology.

[59]  R. Robinson,et al.  Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. , 1975, The New England journal of medicine.

[60]  J. McCutchan,et al.  Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum. , 1975, Transactions of the Association of American Physicians.

[61]  D. Morrison,et al.  DIRECT EVIDENCE FOR HAGEMAN FACTOR (FACTOR XII) ACTIVATION BY BACTERIAL LIPOPOLYSACCHARIDES (ENDOTOXINS) , 1974, The Journal of experimental medicine.

[62]  N. Nielsen,et al.  Preweaning mortality in pigs. 1. Herd investigations. , 1974, Nordisk veterinaermedicin.

[63]  S. Wolff,et al.  Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides and proteins. , 1973, The Journal of infectious diseases.

[64]  E. Ziegler,et al.  Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. , 1973, Journal of immunology.

[65]  A. Braude,et al.  Treatment and prevention of intravascular coagulation with antiserum to endotoxin. , 1973, The Journal of infectious diseases.

[66]  B. Osburn,et al.  Immune responsiveness of the fetus and neonate , 1973 .

[67]  D. Howell.  Survey on mastitis caused by environmental bacteria , 1972, Veterinary Record.

[68]  M. Harper,et al.  Relationship between endotoxin-induced abortion and the synthesis of prostaglandin F. , 1972, Prostaglandins.

[69]  A. Braude,et al.  Passive immunization against the local Shwartzman reaction. , 1972, Journal of immunology.

[70]  F. Rosen,et al.  Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). , 1970, The New England journal of medicine.

[71]  H. Dupont,et al.  INFECTIONS DUE TO GRAM-NEGATIVE ORGANISMS: AN ANALYSIS OF 860 PATIENTS WITH BACTEREMIA AT THE UNIVERSITY OF MINNESOTA MEDICAL CENTER, 1958–1966 , 1969, Medicine.

[72]  L. Chedid,et al.  A proposed mechanism for natural immunity to enterobacterial pathogens. , 1968, Journal of immunology.

[73]  D. Rifkind.  Prevention by polymyxin B of endotoxin lethality in mice , 1967, Journal of bacteriology.

[74]  I. Berczi,et al.  Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. , 1966, Canadian journal of microbiology.

[75]  O. Westphal,et al.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae. , 1966, Bacteriological reviews.

[76]  A. Elbein,et al.  THE BIOSYNTHESIS OF CELL WALL LIPOPOLYSACCHARIDE IN ESCHERICHIA COLI. I. THE BIOCHEMICAL PROPERTIES OF A URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASELESS MUTANT. , 1965, The Journal of biological chemistry.

[77]  C. E. Rice,et al.  Complement Titres of Naturally and Artificially Raised Piglets: I. In piglets of different birth weights. , 1963, Canadian journal of comparative medicine and veterinary science.

[78]  A. Braude.  Transfusion reactions from contaminated blood; their recognition and treatment. , 1958, The New England journal of medicine.

[79]  W. H. Hall,et al.  Fatal transfusion reactions from massive bacterial contamination of blood. , 1951, The New England journal of medicine.

[80]  I. L. Bennett,et al.  The properties and biologic effects of bacterial pyrogens. , 1950, Medicine.

[81]  W. Spink,et al.  Aureomycin therapy in human brucellosis due to Brucella melitensis. , 1948 .

[82]  F. Seibert,et al.  THE CAUSE OF MANY FEBRILE REACTIONS FOLLOWING INTRAVENOUS INJECTIONS: II. The Bacteriology of Twelve Distilled Waters , 1925 .